TherapeuticsMD Inc. Stock Falls 3.8%, Underperforms Market

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of TherapeuticsMD Inc. shed 3.8% to $2.05 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.5% to 27,068.72 and the Dow Jones Industrial Average rising 0.9% to 51,828.62.

This was the stock's second consecutive day of losses.

TherapeuticsMD Inc. closed 30.5% below its 52-week high of $2.95, which the company achieved on January 27th.

The stock underperformed when compared to some of its peers, as AbbVie Inc. fell 0.3% to $264.34.

Trading volume totaled 13,779, compared to the 50-day average of 26,137.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 25, 2026 16:34 ET (20:34 GMT)